Health Condition 1: N978- Female infertility of other origin
Conditions
Interventions
Intervention1: Intraovarian injection of autologous Platelet rich plasma.: Autologous Platelet rich plasma intra ovarian injection will be given between day 7 and day 9 of periods for three consecutiv
Sponsors
VMMC and Safdarjung hospital
Eligibility
Inclusion criteria
Inclusion criteria: Serum AMH (Anti Mullerian Hormone) AFC (Antral Follicle Count) Serum FSH(Follicle Stimulating Hormone) > 12, Hb >11 gm% and platelets >1.5 lakhs.
Exclusion criteria
Exclusion criteria: previous history of Pelvic Inflammatory Disease (PID), Suspected pelvic adhesions, known clinical/biochemical hyperandrogenism or PCOS, Severe male factor infertility, history of symptoms of platelet dysfunction such as easy bruisability, frequent nose-bleeds, heavy menstrual bleeding, bleeding gums or excessive bleeding during dental procedures ,blood borne disease like Hepatitis B, Hepatitis C, Syphilis, HIV, NSAIDs intake in 10 days before the procedure ,patient on anticoagulant therapy, mullerian abnormality, Ashermann Syndrome, moderate /severe endometriosis, active vaginal/cervix infection, any significant co-morbidity/ psychiatric disorder which compromise or interfere with consent giving/study participation/ follow up or interpretation of study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Antral Follicle Count (defined as all follicles of 2-9 mm on day 2 scan on TVS), 2.Serum AMH 3.Serum FSH at the end of the treatment cycle. Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| conception rateTimepoint: after 3 months | — |
Countries
India
Contacts
Public Contactdr Divya Pandey
Vardhman Mahavir Medical College and Safdarjung Hospital
Outcome results
None listed